Yonsei Med J.  2015 Jan;56(1):292-294. 10.3349/ymj.2015.56.1.292.

Bacteroides faecis and Bacteroides intestinalis Recovered from Clinical Specimens of Human Intestinal Origin

• Lee Y
• Kim HS
• Yong D
• Jeong SH
• Lee K
• Chong Y

• KMID: 2352819
• DOI: http://doi.org/10.3349/ymj.2015.56.1.292

Abstract

We report three cases of recently named Bacteroides spp. isolates, two B. faecis isolates and one B. intestinalis isolate from clinical specimens of inpatients at a Korean tertiary-care hospital in 2011. All isolates were susceptible to piperacillin-tazobactam, imipenem, meropenem, chloramphenicol, and metronidazole.

Keyword

Bacteroides faecis; Bacteroides intestinalis

MeSH Terms

Aged
Anti-Bacterial Agents/pharmacology
Bacteroides/drug effects/*isolation & purification
Female
Humans
Intestines/*microbiology
Male
Microbial Sensitivity Tests
Middle Aged
Anti-Bacterial Agents

Reference

1. Kononen E, Wade WG, Citron DM. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic gram-negative rods. In : Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of clinical microbiology. 10th ed. Washington, DC: ASM Press;2011. p. 858–880.

2. Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJ, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother. 2007; 51:1649–1655.

3. Park Y, Lee Y, Kim M, Choi JY, Yong D, Jeong SH, et al. Recent trends of anaerobic bacteria isolated from clinical specimens and clinical characteristics of anaerobic bacteremia. Infect Chemother. 2009; 41:216–223.

4. Bakir MA, Kitahara M, Sakamoto M, Matsumoto M, Benno Y. Bacteroides finegoldii sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2006; 56(Pt 5):931–935.

5. Bakir MA, Kitahara M, Sakamoto M, Matsumoto M, Benno Y. Bacteroides intestinalis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2006; 56(Pt 1):151–154.

6. Bakir MA, Sakamoto M, Kitahara M, Matsumoto M, Benno Y. Bacteroides dorei sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2006; 56(Pt 7):1639–1643.

7. Simmon KE, Mirrett S, Reller LB, Petti CA. Genotypic diversity of anaerobic isolates from bloodstream infections. J Clin Microbiol. 2008; 46:1596–1601.

8. Song YL, Liu CX, McTeague M, Finegold SM. "Bacteroides nordii" sp. nov. and "Bacteroides salyersae" sp. nov. isolated from clinical specimens of human intestinal origin. J Clin Microbiol. 2004; 42:5565–5570.

9. Kim MS, Roh SW, Bae JW. Bacteroides faecis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 2010; 60(Pt 11):2572–2576.

10. Clinical Laboratory Standards Institute (CLSI). Methods for antimicrobial susceptibility testing of anaerobic bacteria. Clinical and Laboratory Standards Institute document M11-A7. 7th ed. Wayne, PA: CLSI;2007.

11. Lee Y, Park Y, Kim MS, Yong D, Jeong SH, Lee K, et al. Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea. Antimicrob Agents Chemother. 2010; 54:3993–3997.